DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...
In this interview, we speak to Keith Olson and Coby Carlson from FUJIFILM Cellular Dynamics about their iPSC technology and how it is making breakthroughs in blood-brain barrier research. Please can ...
In the last decade, induced pluripotent stem cells have opened the floodgates for studying human biology in a dish, or well, as the case may be. However, the genetic heterogeneity of human cells makes ...
Neurodegenerative diseases affect about 15 % of the global population and are on the rise due to aging demographics. Neuroinflammation, driven by the brain’s immune cells known as microglia, is a key ...
Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...
Taiwan’s biotech industry is living its golden days, and LumiSTAR is certainly one of its shining examples. It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and ...
CAMBRIDGE, Mass. & ATLANTA & SEOUL, South Korea--(BUSINESS WIRE)--Cellino, a biotechnology company pioneering autonomous biomanufacturing for personalized regenerative medicine, today announced its ...
BEACHWOOD, Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs ...
Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback